Tandem Diabetes Care designs, manufactures, and commercializes intelligent insulin delivery systems and diabetes management technologies for insulin-dependent patients worldwide. The company's core products are the t:slim X2 and Tandem Mobi insulin pumps, which incorporate hybrid closed-loop algorithms to automatically predict and prevent dangerous blood sugar fluctuations; these platforms are complemented by software tools and data management platforms that help patients and healthcare providers monitor and manage therapy. Tandem generates revenue from the initial sale of durable insulin pumps and recurring supplies such as cartridges and infusion sets that patients replace every few days, reaching customers through a hybrid model combining direct sales in developed markets with distributor partnerships, particularly in international regions.